Transdermal Delivery Kydonieus Foundation Award

About the Award

The Controlled Release Society Transdermal Delivery Kydonieus Foundation Award recognizes CRS members who have made outstanding contributions to the field of transdermal delivery science and technology over a minimum of five (5) years. Contributions may have been technical, scientific, and/or managerial in the field of transdermal delivery commercial development, education, and/or leadership within the areas of interest to CRS.

Criteria

  • Nominee must be an established investigator who has made an outstanding innovative contribution in the area of transdermal delivery.
  • Nominees for the award may be from academia, industry, or government and may be representative of all demographic groups.
  • Nominees must be a current CRS member.

Service and leadership within CRS will be considered, but is not a requirement for the receiving of Transdermal Delivery Kydonieus Foundation Award

Nominations

Submit here

All nominations for the primary CRS awards are submitted through the same form for consideration. Please note, that self-nominations are greatly encouraged. The following areas will be reviewed for eligibility by the Award Committee:

  • Contributions to Drug Delivery Science (50%)
  • Contributions to the Controlled Release Society (30%)
  • Contributions to Equality, Diversity and Inclusion (20%)
  • A CV for the nominee is required 

Nomination period: January 15, 2024 – March 15, 2024 11:59 pm ET.

Selection Process

The Transdermal Kydonieus Award Committee will make the selection of the awardee. The committee is comprised of a Chair selected by the CRS Awards Board Liaison, 1 previous winner, 1 College of Fellows member, and 1 Skin and Mucosal (previously Transdermal and Mucosal) Focus Group past Chair.

Award

  • Award Plaque presented at the Annual Meeting
  • $3,000 USD Honorarium presented at the Annual Meeting

Past Recipients